At a glance
- Originator Ono Pharmaceutical
- Class Anti-inflammatories; Anti-ischaemics; Antirheumatics; Propiophenones; Small molecules
- Mechanism of Action Cyclooxygenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Ischaemic heart disorders; Rheumatic disorders